Alzamend Neuro Inc. (ALZN)
undefined
undefined%
At close: undefined
1.19
0.00%
Pre-market Dec 16, 2024, 04:10 AM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16
Revenue - - - - - - - - -
Cost of Revenue 50.74K 23.07K - - - - - - -
Gross Profit -50.74K -23.07K - - - - - - -
Operating Income -9.94M -14.87M -12.32M -4.95M -4.42M -5.01M -898.43K -1.55M -69.46K
Interest Income - 7.70 46.52 1.71K 13.93K 146.39K 33.23K 21.50K -
Pretax Income -9.95M -14.88M -12.36M -5.05M -4.41M -4.86M -931.66K -1.57M -69.46K
Net Income -9.95M -14.88M -12.40M -5.20M -4.40M -4.86M -931.66K -1.57M -69.46K
Selling & General & Admin 3.48M 7.42M 7.12M 3.64M 3.35M 1.31M 575.03K 1.27M 69.46K
Research & Development 6.46M 7.45M 5.20M 1.31M 1.07M 3.70M 323.40K 275.05K -
Other Expenses 0.00 - - - - - - - -
Operating Expenses 9.94M 14.87M 12.32M 4.95M 4.42M 5.01M 898.43K 1.55M 69.46K
Interest Expense 10.10K 7.70K 46.52K 158.80K - - - - -
Selling & Marketing Expenses 247.33K 742.60K 17.65K - - - 29.91K 330.84K -
Cost & Expenses 9.94M 14.87M 12.32M 4.95M 4.42M 5.01M 898.43K 1.55M 69.46K
Income Tax - -144.83K 42.52K 157.10K -13.93K -146.39K -898.43K -21.50K -
Shares Outstanding (Basic) 676.00K 650.00K 593.00K 484.00K 475.00K 392.00K 568.70K 192.00K 165.00K
Shares Outstanding (Diluted) 676.57K 650.13K 593.97K 484.33K 475.02K 392.29K 568.70K 192.01K 165.30K
EPS (Basic) -14.72 -22.89 -20.92 -10.75 -9.26 -12.4 -1.64 -8.18 -0.42
EPS (Diluted) -14.7 -22.89 -20.88 -10.74 -9.25 -12.4 -1.64 -8.18 -0.42
EBITDA -9.89M -14.85M -12.32M - - - 7.34K -21.50K -
Depreciation & Amortization 50.74K 23.07K 3.55K 4.95M 4.42M 5.01M 898.43K 1.55M 69.46K